Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 20 to 50 Men only

Using Dexmedetomidine or Tramadol with Paracetamol to Reduce Bladder Discomfort After Surgery

Official title: The Effect of Adding Dexmedetomidine or Tramadol to Paracetamol- An Effort to Attenuate Catheter Related Bladder Discomfort: A Randomized, Triple-Blind Clinical Trial

Run by Al-Azhar University · NCT06274333 · Data updated 2026-11-12

This study is testing whether adding Dexmedetomidine or Tramadol to Paracetamol can help reduce bladder discomfort after surgery for people aged 20 to 50.

Quick facts

PhasePhase 3
Study typeInterventional
Ages20 Years to 50 Years
SexMen only
Enrollment60 (estimated)
SponsorAl-Azhar University
Academic / other
Locations1 site (Cairo, Cairo Governorate)
StatusRecruiting
StartedFebruary 28, 2024
Main results expectedAugust 30, 2026
Study endsSeptember 30, 2026
Registry record updatedJanuary 6, 2026
Trial IDNCT06274333 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 20 to 50 years who are classified as ASA I or II and are scheduled for percutaneous nephrolithotomy.

Probably not a fit

Patients with a history of psychotic illnesses, current opioid users, or those with bladder obstruction or overactive bladder may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of adding Dexmedetomidine or Tramadol to Paracetamol in reducing catheter-related bladder discomfort (CRBD) in patients undergoing percutaneous nephrolithotripsy (PCNL). The study aims to evaluate how these medications can alleviate postoperative pain and discomfort associated with urinary catheters. Participants will receive either Dexmedetomidine or Tramadol alongside Paracetamol during their surgical procedure. The trial focuses on patients aged 20 to 50 years with specific health criteria to ensure safety and efficacy.

Why it matters

Potential benefit: If successful, this approach could significantly reduce postoperative bladder discomfort for patients undergoing urinary procedures.

How similar studies have gone: Other studies have shown promising results with similar approaches to managing postoperative pain and discomfort, suggesting potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age from 20 - 50 years
* ASA (The American Society of Anesthesiologists) I or II,
* undergo percutaneous nephrolithotomy (PCNL)

Exclusion Criteria:

* Patients with history of psychotic illnesses
* Opioid users
* Bladder obstruction,
* Benign prostatic hyperplasia
* Overactive bladder (OAB) defined as frequency \_3 times at night or \_8 times within 24 hours.

Where it's running

  • Neveen Kohaf
    Cairo, Cairo Governorate, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.